Table 4 Report quality evaluation included in SRs/MAs by PRISMA 2020
Topic | Â | Item number | Yang AL 2018Â [29] | Wu JH 2019Â [8] | Liu SY 2018Â [6] | Lv YH 2015Â [30] | Li Y 2016Â [31] | Zhang HB 2019Â [7] | Number of y (%) |
|---|---|---|---|---|---|---|---|---|---|
Title | Title | Item 1 | y | y | y | y | y | y | 6(100%) |
Abstract | Abstract | Item 2 | n | py | py | py | py | py | 0(0) |
Introduction | Rationale basis | Item 3 | y | y | y | y | y | y | 6(100%) |
Objectives | Item 4 | y | y | y | y | y | y | 6(100%) | |
Methods | Eligibility criteria | Item 5 | y | py | y | y | y | py | 4(66.67%) |
| Â | Information sources | Item 6 | py | py | y | py | y | y | 3(50%) |
| Â | Search strategy | Item 7 | n | n | y | n | n | n | 1(16.7%) |
| Â | Screening process | Item 8 | y | y | y | y | y | y | 6(100%) |
| Â | Data extraction | Item 9 | n | n | y | y | y | y | 4(66.67%) |
| Â | Data items | Item 10a | y | y | y | py | py | py | 3(50%) |
| Â | Item 10b | y | y | y | y | y | y | 6(100%) | |
| Â | Study risk of bias assessment | Item 11 | y | y | y | y | y | y | 6(100%) |
| Â | Effffect measures | Item 12 | y | y | y | y | y | y | 6(100%) |
| Â | Synthesis methods | Item 13a | y | y | y | y | y | y | 6(100%) |
| Â | Item 13b | y | y | y | y | y | y | 6(100%) | |
| Â | Item 13c | y | y | y | y | y | y | 6(100%) | |
| Â | Item 13d | y | y | y | y | y | y | 6(100%) | |
| Â | Item 13e | n | n | y | n | y | y | 3(50%) | |
| Â | Item 13f | n | y | y | n | n | y | 3(50%) | |
| Â | Reporting bias assessment | Item 14 | n | y | y | y | n | y | 4(66.67%) |
| Â | Quality of outcome evidence | Item 15 | n | n | n | n | n | n | 0(0) |
Results | Study selection | Item 16a | n | y | y | y | y | y | 5(83.3%) |
| Â | Item 16b | n | y | y | y | y | y | 5(83.3%) | |
| Â | Study characteristics | Item 17 | y | y | y | y | y | y | 6(100%) |
| Â | Risk of bias in studies | Item 18 | y | y | y | y | y | y | 6(100%) |
| Â | Results of individual studies | Item 19 | y | y | y | y | y | y | 6(100%) |
| Â | Results of syntheses | Item 20a | py | y | y | y | y | y | 5(83.3%) |
| Â | Item 20b | y | y | y | y | y | y | 6(100%) | |
| Â | Item 20c | n | y | y | n | y | y | 4(66.67%) | |
| Â | Item 20d | n | y | y | n | y | y | 4(66.67%) | |
| Â | Reporting bias | Item 21 | n | y | y | y | n | y | 4(66.67%) |
| Â | Certainty of evidence | Item 22 | n | n | n | n | n | n | 0(0) |
Discussion | Discussion | Item 23a | y | y | y | y | y | y | 6(100%) |
| Â | Item 23b | y | n | y | y | y | y | 5(83.3%) | |
| Â | Item 23c | y | n | y | y | y | y | 5(83.3%) | |
| Â | Item 23d | y | y | y | y | y | y | 6(100%) | |
Other Information | Registration and protocol | Item 24a | n | n | n | n | n | n | 0(0) |
| Â | Item 24b | n | n | n | n | n | n | 0(0) | |
| Â | Item 24c | n | n | n | n | n | n | 0(0) | |
| Â | Supporting | Item 25 | n | n | y | y | n | n | 2(33.3%) |
| Â | Statement of Conflict of Interest | Item 26 | n | n | y | y | y | y | 4(66.67%) |
| Â | Information Availability | Item 27 | n | n | n | n | n | y | 1(16.7%) |